Position in PFE
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$172,832
+$18,801 QoQ
Shares Held
6,155
-0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026McIlrath & Eck, LLC holds $2,576,783 across 13 Drug Manufacturers - General names. PFE ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
855 | $786,403 | |
| 2 | AMGN |
Amgen Inc
|
1,870 | $657,959 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,198 | $264,397 | |
| 4 | ABBV |
AbbVie Inc.
|
1,138 | $247,503 | |
| 5 | PFE |
Pfizer Inc
This page
|
6,155 | $172,832 | |
| 6 | JNJ |
Johnson & Johnson
|
594 | $145,197 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,324 | $140,950 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
585 | $81,531 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $172,832 | 6,155 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $154,031 | 6,186 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $109,640 | 4,303 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $107,310 | 4,427 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $148,340 | 5,854 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $151,167 | 5,698 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $182,148 | 6,294 | Shares | Sole | 2024-11-19 | |
| 2024-06-30 | $198,853 | 7,107 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $194,333 | 7,003 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $211,808 | 7,357 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $255,939 | 7,716 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $305,067 | 8,317 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $378,705 | 9,282 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $414,582 | 8,091 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $329,994 | 7,541 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $409,583 | 7,812 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $365,185 | 7,054 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $416,479 | 7,053 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $325,542 | 7,569 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $294,091 | 7,510 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $279,441 | 7,713 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $290,799 | 7,900 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $226,879 | 6,182 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $158,366 | 4,843 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $124,815 | 3,824 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||